Dual PTK7/GD2 Gamma Delta CAR T Cell Therapy for Neuroblastoma |
Emory University / Kelly Goldsmith, MD & H. Trent Spencer, PhD & Chris B. Doering, PhD |
Reach Grants |
2021 |
Georgia |
Stapled Peptide PROTAC: A 3-in-1 Treatment for Pediatric Solid Tumors |
Dana-Farber Cancer Institute / Loren Walensky, MD/PhD |
Reach Grants |
2021 |
Massachusetts |
Optimization of Drug Efflux and Brain Clearance to Improve CED of Targeted Therapy to H3K27M DMG |
Mayo Clinic / David Daniels, MD/PhD |
Reach Grants |
2021 |
Minnesota |
IND-Enabling Studies for WNTinib, a Novel Selective Therapeutic for CTNNB1 Mutant Hepatoblastomas |
Icahn School of Medicine at Mount Sinai / Ernesto Guccione, PhD & Josep Llovet, MD & Arvin Dar, PhD |
Reach Grants |
2021 |
New York |
The Interplay Between Histone Mutations and Replication Stress in Shaping Glioma Phenotypes |
Dana-Farber Cancer Institute / Pratiti Bandopadhayay, PhD |
'A' Award Grants |
2021 |
Massachusetts |
Circulating Tumor Biomarkers: New Paradigms for Management of Neuroblastoma |
University of Chicago / Mark Applebaum, PhD |
'A' Award Grants |
2021 |
Illinois |
Turning Killers into THINKers: TME Hostility-Impervious NK Cells for Treating Neuroblastoma and Sarcoma |
Baylor College of Medicine / Robin Parihar, MD/PhD |
'A' Award Grants |
2021 |
Texas |
Role of PHF6 Mutations in Germline RUNX1 Deficiency Associated Hematopoietic Disorders |
Boston Children's Hospital / Serine Avagyan, MD/PhD |
RUNX1 Early Career Investigator Grants |
2021 |
Massachusetts |
Genetic Susceptibility to Ototoxicity in Pediatric Germ Cell Tumor Survivors |
University of Minnesota / Jenny Poynter, MPH, PhD |
Epidemiology Grants |
2020 |
Minnesota |
Modeling the Initiation and Progression of Down Syndrome Associated Leukemia Using CRISPR/Cas9 at Single Cell Resolution |
University Health Network / Elvin Wagenblast, PhD |
Young Investigator Grants |
2020 |
Ontario |